Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. DeLellis R, Heitz P, Eng C. Pathology and genetics: tumours of endocrine organs (IARC WHO Classification of Tumours). Lyon, France: IARC Press, 2004.Search in Google Scholar
2. NGS in PPGL (NGSnPPGL) Study Group, Toledo RA, Burnichon N, Cascon A, Benn DE, Bayley JP, Welander J, et al. Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol 2017;13:233–47.10.1038/nrendo.2016.185Search in Google Scholar PubMed
3. Corssmit EP, Romijn JA. Management of endocrine disease; clinical management of paragangliomas. Eur J Endocrinol 2014;171:231–43.10.1530/EJE-14-0396Search in Google Scholar PubMed
4. Osinga TE, van der Horst-Schrivers AN, van Faassen M, Kerstens MN, Dullaart RP, Peters MA, et al. Dopamine concentration in blood platelets is elevated in patients with head and neck paragangliomas. Clin Chem Lab Med 2016;54:1395–401.10.1515/cclm-2015-0631Search in Google Scholar PubMed
5. Osinga TE, Korpershoek E, de Krijger RR, Kerstens MN, Dullaart RP, Kema IP, et al. Catecholamine-synthesizing enzymes are expressed in parasympathic head and neck paraganglioma tissue. Neuroendocrinology 2015;101:289–95.10.1159/000377703Search in Google Scholar PubMed
6. King KS, Chen CC, Alexopoulos DK, Whatley MA, Reynolds JC, Patronas N, et al. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab 2011;96:2779–85.10.1210/jc.2011-0333Search in Google Scholar PubMed PubMed Central
7. Osinga TE, Kerstens MN, van der Klauw MM, Koornstra JJ, Wolffenbuttel BH, Links TP, et al. Intestinal pseudo-obstruction as a complication of paragangliomas: case report and literature review. Neth J Med 2013;71:512–7.Search in Google Scholar
8. Van Hulsteijn LT, van Duinen N, Romijn JA, Smit JW, Corssmit EP. Urinary 5-HIAA excretion is not increased in patients with head and neck paragangliomas. Int J Biol Markers 2012;27:160–3.10.5301/JBM.2012.9312Search in Google Scholar PubMed
9. Meijer WG, Kema IP, Volmer M, Willemse PH, de Vries EG. Discriminating capacity of indole markers in the diagnosis of carcinoid tumors. Clin Chem 2000;46:1588–96.10.1093/clinchem/46.10.1588Search in Google Scholar
10. de Jong WH, Wilkens MH, de Vries EG, Kema IP. Automated mass spectrometric analysis of urinary and plasma serotonin. Anal Bioanal Chem 2010;396:2609–16.10.1007/s00216-010-3466-5Search in Google Scholar PubMed PubMed Central
©2018 Walter de Gruyter GmbH, Berlin/Boston
